Cargando…

Evaluation of the Abbott Panbio(TM) COVID-19 Ag rapid antigen test for the detection of SARS-CoV-2 in asymptomatic Canadians

Several rapid testing methodologies have been approved for testing of symptomatic individuals but have not been validated for asymptomatic screening. We evaluated performance of the Abbott PanbioTM COVID-19 rapid antigen assay in the asymptomatic setting. We conducted a prospective study in an urban...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shaw, Julie L V, Deslandes, Vincent, Smith, Jennifer, Desjardins, Marc
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8324400/ https://www.ncbi.nlm.nih.gov/pubmed/34418823 http://dx.doi.org/10.1016/j.diagmicrobio.2021.115514

Ejemplares similares

Evaluation of the diagnostic performance of PanbioTM Abbott SARS-CoV-2 rapid antigen test for the detection of COVID-19 from suspects attending ALERT center
por: Ashagre, Wondimu, et al.
Publicado: (2022)

Performance evaluation of Roche and Abbott Panbio multiplex SARS-CoV-2 and influenza A/B rapid antigen tests
por: Batty, Mitchell, et al.
Publicado: (2023)

Screening for SARS-CoV-2 infection in asymptomatic individuals using the Panbio COVID-19 antigen rapid test (Abbott) compared with RT-PCR: a prospective cohort study
por: Winkel, Beatrice, et al.
Publicado: (2021)

Real-life validation of the Panbio™ COVID-19 antigen rapid test (Abbott) in community-dwelling subjects with symptoms of potential SARS-CoV-2 infection
por: Gremmels, Hendrik, et al.
Publicado: (2020)

Evaluation of the Abbott Panbio(™) COVID-19 antigen detection rapid diagnostic test among healthcare workers in elderly care
por: Eikelenboom-Boskamp, Andrea, et al.
Publicado: (2023)

A comparative evaluation between the Abbott Panbio™ COVID-19 IgG/IgM rapid test device and Abbott Architect™ SARS CoV-2 IgG assay
por: Batra, Rahul, et al.
Publicado: (2020)

The Abbott PanBio WHO emergency use listed, rapid, antigen-detecting point-of-care diagnostic test for SARS-CoV-2—Evaluation of the accuracy and ease-of-use
por: Krüger, Lisa J., et al.
Publicado: (2021)

Evaluation of a rapid antigen test (Panbio™ COVID-19 Ag rapid test device) for SARS-CoV-2 detection in asymptomatic close contacts of COVID-19 patients
por: Torres, Ignacio, et al.
Publicado: (2021)

Implementation of the Abbott ID Now COVID-19 assay at a tertiary care center: a prospective pragmatic implementation study during the third wave of SARS-CoV-2 in Ontario
por: Deslandes, Vincent, et al.
Publicado: (2022)

Evaluation of the performance of Abbott Panbio™ COVID-19 antigen rapid diagnostic test for the detection of severe acute respiratory syndrome coronavirus 2 at Harar, Eastern Ethiopia
por: Teklemariam, Zelalem, et al.
Publicado: (2023)

Diagnostic accuracy of Panbio™ rapid antigen test for SARS-CoV-2 in paediatric population
por: Gallardo-Alfaro, Laura, et al.
Publicado: (2023)

Clinical performance of the Abbott Panbio with nasopharyngeal, throat, and saliva swabs among symptomatic individuals with COVID-19
por: Stokes, William, et al.
Publicado: (2021)

Experience with Panbio™ rapid antigens test device for the detection of SARS-CoV-2 in nursing homes()
por: Domínguez Fernández, Mercedes, et al.
Publicado: (2022)

Diagnostic accuracy of Panbio rapid antigen tests on oropharyngeal swabs for detection of SARS-CoV-2
por: Ngo Nsoga, Marie Thérèse, et al.
Publicado: (2021)

Low sensitivity of the COVID-19 antigen test (PANBIO™ COVID-19 Ag rapid test) to detect asymptomatic infections in health personnel of the National Institute of Respiratory Diseases
por: Becerril Vargas, Eduardo, et al.
Publicado: (2022)

Performance Evaluation of the STANDARD(TM) Q COVID-19 and Panbio(TM) COVID-19 Antigen Tests in Detecting SARS-CoV-2 during High Transmission Period in Mozambique
por: Sitoe, Nádia, et al.
Publicado: (2022)

Diagnostic performance of CerTest and Panbio antigen rapid diagnostic tests to diagnose SARS-CoV-2 infection
por: Pérez-García, Felipe, et al.
Publicado: (2021)

Multicenter evaluation of the Panbio™ COVID-19 rapid antigen-detection test for the diagnosis of SARS-CoV-2 infection
por: Merino, Paloma, et al.
Publicado: (2021)

Evaluation of Panbio rapid antigen test for SARS‐CoV‐2 in symptomatic patients and their contacts: a multicenter study
por: Thirion-Romero, Ireri, et al.
Publicado: (2021)

Analytical and clinical performance of the panbio COVID-19 antigen-detecting rapid diagnostic test
por: Alemany, Andrea, et al.
Publicado: (2021)

Detection of SARS-CoV-2 antibodies after confirmed Omicron BA.1 and presumed BA.4/5 infections using Abbott ARCHITECT and Panbio assays
por: Boler, Michael, et al.
Publicado: (2023)

Field evaluation of a rapid antigen test (Panbio™ COVID-19 Ag Rapid Test Device) for COVID-19 diagnosis in primary healthcare centres
por: Albert, Eliseo, et al.
Publicado: (2021)

Validation and implementation of the Panbio COVID-19 Ag rapid test for the diagnosis of SARS-CoV-2 infection in symptomatic hospital healthcare workers
por: Kolwijck, E., et al.
Publicado: (2021)

Detection of the Omicron Variant Virus With the Abbott BinaxNow SARS-CoV-2 Rapid Antigen Assay
por: Regan, James, et al.
Publicado: (2022)

Panbio™ rapid antigen test for SARS-CoV-2 has acceptable accuracy in symptomatic patients in primary health care
por: Bulilete, Oana, et al.
Publicado: (2021)

Evaluación de la validez del Ag PANBIO-COVID19 de Abbott en el diagnóstico de la infección por SARS-CoV-2 en pacientes asintomáticos o con infección leve
por: Gras-Valenti, Paula, et al.
Publicado: (2021)

Clinical application of the Panbio™ COVID-19 Ag rapid test device and SSf-COVID19 kit for the detection of SARS-CoV-2 infection
por: Oh, Sang-Min, et al.
Publicado: (2022)

Panbio antigen rapid test is reliable to diagnose SARS-CoV-2 infection in the first 7 days after the onset of symptoms
por: Linares, Manuel, et al.
Publicado: (2020)

Evaluation of the performance of Panbio™ COVID-19 antigen rapid diagnostic test for the detection of SARS-CoV-2 in suspected patients in Ethiopia
por: Dessalegn, Dejene, et al.
Publicado: (2022)

Laboratory and field evaluation of the STANDARD Q and Panbio(™) SARS-CoV-2 antigen rapid test in Namibia using nasopharyngeal samples
por: Konstantinus, Iyaloo, et al.
Publicado: (2022)

Assessment of the Abbott BinaxNOW SARS-CoV-2 rapid antigen test against viral variants of concern
por: Rao, Anuradha, et al.
Publicado: (2022)

Evaluation of the Panbio™ COVID-19 ag rapid test at an emergency room in a hospital in São Paulo, Brazil
por: Faíco-Filho, Klinger Soares, et al.
Publicado: (2022)

Diagnostic accuracy of the Panbio COVID-19 antigen rapid test device for SARS-CoV-2 detection in Kenya, 2021: A field evaluation
por: Irungu, Jack Karuga, et al.
Publicado: (2023)

Diagnostic accuracy of SARS-CoV-2 Panbio™ rapid antigen diagnostic tests in a 4,440-case clinical follow-up
por: Hamar, Ágoston, et al.
Publicado: (2022)

Detection of SARS-CoV-2 variants by Abbott molecular, antigen, and serological tests
por: Rodgers, Mary A, et al.
Publicado: (2022)

Evaluation of the Panbio COVID-19 Rapid Antigen Detection Test Device for the Screening of Patients with COVID-19
por: Fenollar, Florence, et al.
Publicado: (2021)

Evaluation of the Panbio COVID-19 Antigen Rapid Diagnostic Test in Subjects Infected with Omicron Using Different Specimens
por: Galliez, Rafael Mello, et al.
Publicado: (2022)

Analytical Sensitivity of the Abbott BinaxNOW COVID-19 Ag Card
por: Perchetti, Garrett A., et al.
Publicado: (2021)

Field performance evaluation of the PanBio rapid SARS-CoV-2 antigen assay in an epidemic driven by the B.1.351 variant in the Eastern Cape, South Africa
por: Akingba, Oluwakemi Laguda, et al.
Publicado: (2021)

Evaluation of the Abbott BinaxNOW rapid antigen test for SARS-CoV-2 infection in children: Implications for screening in a school setting
por: Sood, Neeraj, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_351u68lkleb298hg942oge78jl